MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
31.31
+0.77 (2.52%)
At close: Mar 4, 2026, 4:00 PM EST
31.31
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:27 PM EST
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.48 billion as of March 4, 2026. Its market cap has increased by 324.40% in one year.
Market Cap
1.48B
Enterprise Value
1.13B
1-Year Change
324.40%
Ranking
Category
Stock Price
$31.31
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.48B, an increase of 189.68%. That is a compound annual growth rate of 106.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.44B | 1.68% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 1.61B |
| Ardelyx | 1.59B |
| Biohaven | 1.57B |
| Iovance Biotherapeutics | 1.56B |
| Tango Therapeutics | 1.55B |
| Nanobiotix | 1.53B |
| AnaptysBio | 1.52B |
| EyePoint | 1.52B |